These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31147194)

  • 1. Occurrence, mortality and predictors of complicated cardiac perforation in patients with CRT-D: Based on the National Inpatient Sample registry.
    Kawata H; Erande A; Lafi O; Chen CW; Hirai T; Santucci P; Malik S
    Int J Cardiol; 2019 Oct; 293():109-114. PubMed ID: 31147194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States.
    Patel N; Viles-Gonzalez J; Agnihotri K; Arora S; Patel NJ; Aneja E; Shah M; Badheka AO; Pothineni NV; Kancharla K; Mulpuru S; Noseworthy PA; Kusumoto F; Cha YM; Deshmukh AJ
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1425-1435. PubMed ID: 30016005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and outcomes of cardiac tamponade in patients undergoing cardiac resynchronization therapy.
    Adegbala O; Olagoke O; Adejumo A; Akintoye E; Oluwole A; Alebna P; Williams K; Lieberman R; Afonso L
    Int J Cardiol; 2018 Dec; 272():137-141. PubMed ID: 30045818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device-related infective endocarditis in cardiac resynchronization therapy recipients - Single center registry with over 2500 person-years follow up.
    Jędrzejczyk-Patej E; Mazurek M; Kowalski O; Sokal A; Kozieł M; Adamczyk K; Przybylska-Siedlecka K; Morawski S; Liberska A; Szulik M; Podolecki T; Kowalczyk J; Kalarus Z; Lenarczyk R
    Int J Cardiol; 2017 Jan; 227():18-24. PubMed ID: 27846457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
    Kramer DB; Normand ST; Volya R; Hatfield LA
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.
    Hosseini SM; Moazzami K; Rozen G; Vaid J; Saleh A; Heist KE; Vangel M; Ruskin JN
    Eur Heart J; 2017 Jul; 38(27):2122-2128. PubMed ID: 28329322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy.
    Aktas MK; Zareba W; Huang DT; McNitt S; Polonsky S; Chen L; Stockburger M; Merkely B; Moss AJ; Kutyifa V
    J Card Fail; 2014 Mar; 20(3):183-9. PubMed ID: 24361804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
    Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
    Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry).
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Am J Cardiol; 2018 Jan; 121(1):55-61. PubMed ID: 29102348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of institutional procedural volume on inhospital outcomes after cardiac resynchronization therapy device implantation: US national database 2003-2011.
    Yeo I; Kim LK; Lerman BB; Cheung JW
    Heart Rhythm; 2017 Dec; 14(12):1826-1832. PubMed ID: 28917564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study.
    Sridhar AR; Yarlagadda V; Yeruva MR; Kanmanthareddy A; Vallakati A; Dawn B; Lakkireddy D
    Europace; 2015 Oct; 17(10):1548-54. PubMed ID: 25855676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
    Unsworth JD; Zaidi A; Hargreaves MR
    Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.
    Cheung JW; Ip JE; Markowitz SM; Liu CF; Thomas G; Feldman DN; Swaminathan RV; Lerman BB; Kim LK
    Heart Rhythm; 2017 Jul; 14(7):1043-1050. PubMed ID: 28214565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.